BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27230848)

  • 41. PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism.
    Matsumoto Y; Rottapel R
    Trends Mol Med; 2023 May; 29(5):390-405. PubMed ID: 36948987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.
    Carvalho VM; Perdigão PF; Amaral FR; de Souza PE; De Marco L; Gomez RS
    Oral Dis; 2009 Jan; 15(1):106-10. PubMed ID: 19017279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism.
    Imai Y; Kanno K; Moriya T; Kayano S; Seino H; Matsubara Y; Yamada A
    Cleft Palate Craniofac J; 2003 Nov; 40(6):632-8. PubMed ID: 14577811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cherubism. A case report.
    Cariati P; Monsalve Iglesias F; Fernández Solís J; Valencia Laseca A; Martinez Lara I
    Reumatol Clin; 2017; 13(6):352-353. PubMed ID: 27427211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel mutation in the SH3BP2 gene causes cherubism: case report.
    Li CY; Yu SF
    BMC Med Genet; 2006 Dec; 7():84. PubMed ID: 17147794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma.
    Teixeira RC; Horz HP; Damante JH; Garlet GP; Santos CF; Nogueira RL; Cavalcante RB; Conrads G
    Int J Oral Maxillofac Surg; 2011 Aug; 40(8):851-5. PubMed ID: 21680150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic and Molecular Characteristics of Familial Cherubism with Associated Odontogenic Tumorous Proliferations.
    Argyris PP; Gopalakrishnan R; Hu Y; Reichenberger EJ; Koutlas IG
    Head Neck Pathol; 2018 Mar; 12(1):136-144. PubMed ID: 28721660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model.
    Mukai T; Akagi T; Hiramatsu Asano S; Tosa I; Ono M; Kittaka M; Ueki Y; Yahagi A; Iseki M; Oohashi T; Ishihara K; Morita Y
    Oral Dis; 2023 Apr; 29(3):1089-1101. PubMed ID: 34743383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variable expressivity familial cherubism: woman transmitting cherubism without suffering the disease.
    Pérez-Sayáns M; Barros-Angueira F; Suárez-Peñaranda JÉ; García-García A
    Head Face Med; 2013 Nov; 9():33. PubMed ID: 24382142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel treatment of a rare genetic bone disease.
    McMahon MS
    Orthopedics; 2007 Feb; 30(2):91. PubMed ID: 17323628
    [No Abstract]   [Full Text] [Related]  

  • 51. Cherubism: a systematic literature review of clinical and molecular aspects.
    Chrcanovic BR; Guimarães LM; Gomes CC; Gomez RS
    Int J Oral Maxillofac Surg; 2021 Jan; 50(1):43-53. PubMed ID: 32620450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A c.1244G>A (p.Arg415Gln) mutation in SH3BP2 gene causes cherubism in a Turkish family: report of a family with review of the literature.
    Sekerci AE; Balta B; Dundar M; Hu Y; Reichenberger EJ; Etoz OA; Nazlim S; Bayrakdar IS
    Med Oral Patol Oral Cir Bucal; 2014 Jul; 19(4):e340-4. PubMed ID: 24608212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma.
    de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
    Br J Oral Maxillofac Surg; 2007 Sep; 45(6):499-500. PubMed ID: 16713042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cherubism].
    Brix M; Peters H; Lebeau J
    Rev Stomatol Chir Maxillofac; 2009 Nov; 110(5):293-8. PubMed ID: 19836038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cherubism - new hypotheses on pathogenesis and therapeutic consequences.
    Hyckel P; Berndt A; Schleier P; Clement JH; Beensen V; Peters H; Kosmehl H
    J Craniomaxillofac Surg; 2005 Feb; 33(1):61-8. PubMed ID: 15694152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of a Norwegian cherubism cohort; molecular genetic findings, oral manifestations and quality of life.
    Prescott T; Redfors M; Rustad CF; Eiklid KL; Geirdal AØ; Storhaug K; Jensen JL
    Eur J Med Genet; 2013 Mar; 56(3):131-7. PubMed ID: 23298620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and genetic analysis of patients with cherubism.
    Machado RA; Pontes H; Pires FR; Silveira HM; Bufalino A; Carlos R; Tuji FM; Alves D; Santos-Silva AR; Lopes MA; Capistrano HM; Coletta RD; Fonseca FP
    Oral Dis; 2017 Nov; 23(8):1109-1115. PubMed ID: 28644570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Genetic aspects of cherubism].
    Brix M; Peters H; Ranfaing E; Ricbourg B
    Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):105-8. PubMed ID: 16738517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cherubism Study Results May Apply to Common Inflammatory Bone Diseases.
    Dent Today; 2015 May; 34(5):54. PubMed ID: 26473261
    [No Abstract]   [Full Text] [Related]  

  • 60. Autoinflammatory bone disorders.
    Ferguson PJ; El-Shanti HI
    Curr Opin Rheumatol; 2007 Sep; 19(5):492-8. PubMed ID: 17762617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.